<DOC>
	<DOCNO>NCT01376063</DOCNO>
	<brief_summary>The primary purpose study assess effect multiple dose FG-4592 plasma pharmacokinetic rosiglitazone healthy adult subject .</brief_summary>
	<brief_title>Study Investigate Interaction Between FG-4592 Rosiglitazone Healthy Adult Subjects</brief_title>
	<detailed_description />
	<mesh_term>Rosiglitazone</mesh_term>
	<criteria>Healthy adult male , 18 45 year Body weight â‰¥ 75 kg Good health Nonsmoker Blood pressure great 140/90 mm Hg Positive following : Human immunodeficiency virus ( HIV ) , hepatitis B surface antigen ( HBsAg ) antihepatitis C virus antibody ( antiHCV Ab ) Blood donation significant blood loss within 60 day prior Day 1 Use prescription counter medications/herbal preparation allow within 14 day prior Day 1 treatment phase History presence alcoholism drug abuse within 2 year prior Day 1 Consumption alcohol within 7 day prior Day 1 treatment phase Positive urine drug/alcohol test screen checkin visit</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>